The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases is a research institute that seeks to investigate the cause of human diseases at the cellular and molecular levels, using DNA and protein technologies to elucidate disease mechanisms.
Its development and progress are of particular interest for future planning in the increasingly important area of clinical research. The Institute endeavors to design methods of rational therapy and, wherever possible, strategies for the prevention of human diseases.
Submissions from 2022
Temporal and Spatial Metabolite Dynamics Impart Control in Adipogenesis, Kristin Eckel-Mahan
The Challenges and Opportunities of scRNA-Seq in COVID-19 Research and Clinical Translation, Wendao Liu, Xiaohua Ye, Zhiqiang An, et al.
The Circular RNA Edis Regulates Neurodevelopment and Innate Immunity, Xiao-Peng Xiong, Weihong Liang, Wei Liu, et al.
The Origin of Bladder Cancer From Mucosal Field Effects, Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
The Rheumatoid Arthritis Drug Auranofin Lowers Leptin Levels and Exerts Antidiabetic Effects in Obese Mice, Aaron R Cox, Peter M Masschelin, Pradip K Saha, et al.
The Temporal Impulse Response Function In Infantile Nystagmus, Gal Avital, Felicia Kuperwaser, Andrew W Pountain, et al.
Uncloaking Cell-Impermeant Gold Nanorods Via Tumor Microenvironmental Cathepsin B Facilitates Cancer Cell Penetration and Potent Radiosensitization, Subhiksha Raghuram, Yuri Mackeyev, Jessica Symons, et al.
Whole Genome Sequence Analysis of Blood Lipid Levels in >66,000 Individuals, Margaret Sunitha Selvaraj, Xihao Li, Zilin Li, et al.
Whole Genome Sequencing Identifies Structural Variants Contributing to Hematologic Traits in the Nhlbi topmed Program, Marsha M Wheeler, Adrienne M Stilp, Shuquan Rao, et al.
Theses/Dissertations from 2016
Genomic Drivers of Cutaneous Squamous Cell Carcinoma Development, Vida Chitsazzadeh
Submissions from 2007
An Innovative Approach to Impacting Student Academic Achievement and Attitudes: Pilot Study of the HEADS UP Virtual Molecular Biology Lab, Melanie M. Mowry MPH, Ross Shegog PhD, Nathalie Sessions BBA, et al.